Eagle Global Scientific
Eagle Global Scientific (EGS) is a Life Sciences company dedicated to supporting clinical and research communities through a wide array of medical and scientific expertise. The company is committed to advancing public health, military medicine, regenerative medicine, infectious disease research, and precision medicine, with a mission to enhance global health and prosperity. EGS is a small business, an Alaska Native Corporation (ANC), and a prime contractor for multiple federal programs, including OASIS+ and 8(a) contracts. The company emphasizes ethical research, innovative diagnostics, and effective communication in public health emergencies.
Industries
Nr. of Employees
medium (51-250)
Eagle Global Scientific
Products
Clinical Research Molecular Bioinformatics support
Support services providing human variant, transcriptomic, methylomic, and metagenomic profiling and analysis for principal investigators relying on whole genome comparisons and modern molecular biology.
CDC Bioinformatics Support
Bioinformatics support bringing advanced technologies, including next-generation sequencing and bioinformatics, into the US public health system to support infectious disease surveillance and outbreak response.
BioMosaic
A web-based and mobile-based geospatial data tool that consolidates complex data from multiple sources into a unified visual format to perform risk assessment and data management for public health emergencies.
FilmArray
An integrated diagnostic instrument system that combines sample preparation, amplification, detection, and analysis into one simple system for respiratory pathogen diagnosis.
Zika Pregnancy of Interest Navigation Tool (Z-POINT)
A data tool created within the Microsoft Access platform to streamline Zika emergency response analytics, classify cases according to standardized definitions, and simplify complex reviews.
Kindenga
A mobile application developed to provide early warning of outbreaks of mosquito-borne diseases in the region of the U.S.-Mexico border through weekly user symptom surveys.
Clinical Research Molecular Bioinformatics support
Support services providing human variant, transcriptomic, methylomic, and metagenomic profiling and analysis for principal investigators relying on whole genome comparisons and modern molecular biology.
CDC Bioinformatics Support
Bioinformatics support bringing advanced technologies, including next-generation sequencing and bioinformatics, into the US public health system to support infectious disease surveillance and outbreak response.
BioMosaic
A web-based and mobile-based geospatial data tool that consolidates complex data from multiple sources into a unified visual format to perform risk assessment and data management for public health emergencies.
FilmArray
An integrated diagnostic instrument system that combines sample preparation, amplification, detection, and analysis into one simple system for respiratory pathogen diagnosis.
Zika Pregnancy of Interest Navigation Tool (Z-POINT)
A data tool created within the Microsoft Access platform to streamline Zika emergency response analytics, classify cases according to standardized definitions, and simplify complex reviews.
Kindenga
A mobile application developed to provide early warning of outbreaks of mosquito-borne diseases in the region of the U.S.-Mexico border through weekly user symptom surveys.
Services
Protocol development, IRB guidance, multisite study coordination, participant recruitment, data collection and reporting.
Pipeline development, algorithm development, variant/transcriptomic/methylomic analysis, and data management for large sequencing datasets.
Personnel deployment, EOC/JIC support, emergency communications, and surge operational coordination for epidemics and disasters.
Clinical laboratory consulting, surge testing staff, assay validation, and field evaluation of point-of-care molecular diagnostics.
Medical and technical writing, editorial project management, development of digital/broadcast materials and policy communications.
Data aggregation, modeling, dashboard creation, ad hoc reporting, and application of statistical methods for health systems and program evaluation.
Protocol development, IRB guidance, multisite study coordination, participant recruitment, data collection and reporting.
Pipeline development, algorithm development, variant/transcriptomic/methylomic analysis, and data management for large sequencing datasets.
Personnel deployment, EOC/JIC support, emergency communications, and surge operational coordination for epidemics and disasters.
Clinical laboratory consulting, surge testing staff, assay validation, and field evaluation of point-of-care molecular diagnostics.
Medical and technical writing, editorial project management, development of digital/broadcast materials and policy communications.
Data aggregation, modeling, dashboard creation, ad hoc reporting, and application of statistical methods for health systems and program evaluation.
Expertise Areas
- Surveillance and epidemiology
- Infectious disease outbreak response
- Molecular diagnostics and assay validation
- Bioinformatics and genomic analysis
Key Technologies
- Next-generation sequencing (NGS)
- Sanger sequencing
- Pyrosequencing
- Bioinformatics pipelines and algorithm development
News & Updates
A review of EGS's activities and achievements from 2020 to 2025.
EGS was selected as a contractor for OASIS+ in the research and development domains.
A research poster presented at the 2016 EIS Conference.
Details about the 2018 conference with images and summaries.
EGS was selected as a One Acquisition Solution for Integrated Services Plus (OASIS+) IDIQ Contractor for both Small Business (SB) and 8(a) in the R&D domains.
A review of EGS's activities and achievements from 2020 to 2025.
EGS was selected as a contractor for OASIS+ in the research and development domains.
A research poster presented at the 2016 EIS Conference.
Details about the 2018 conference with images and summaries.
EGS was selected as a One Acquisition Solution for Integrated Services Plus (OASIS+) IDIQ Contractor for both Small Business (SB) and 8(a) in the R&D domains.